HomeAustralia: Brandon BioCatalyst and ANDHealth selected for BMTI programme
ArticlesNews

Australia: Brandon BioCatalyst and ANDHealth selected for BMTI programme

By Nick Herbert
-

Brandon BioCatalyst, in partnership with ANDHealth, has been selected by the Australian Federal Government to deliver the A$50m (US$33.3m) BioMedTech Incubator (BMTI) programme. The investment, from the A$20bn Medical Research Future…

Subscription required

This content is for Subscribers only. To access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Subscribe
Already have an account?
Previous article
Denmark: DanCann Pharma goes direct to write down debt
Next article
Australia: ACL makes off-market bid for Healius
Nick Herbert
Nick Herbert
Nick Herbert has over 30 years’ experience in the financial markets, as both a practitioner and journalist. He started work as an investment banker in London, before joining International Financing Review (IFR) to report on debt capital markets and derivatives. He moved to Singapore in 2000 to manage IFR’s financial markets editorial team throughout Asia, before returning to London in 2009 to take up the position of Publisher for Reuters Capital Markets Publications. For the last five years he has been covering global capital markets, ESG finance and healthcare markets on a freelance basis.
Related Articles
More From Author

…

Subscription required

This content is for Subscribers only. To access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Subscribe
Already have an account?

…

Subscription required

This content is for Subscribers only. To access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Subscribe
Already have an account?
Advertisement

Related Resources

Related Events